These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16269973)

  • 21. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B
    Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up after tight control of blood pressure in type 2 diabetes.
    Holman RR; Paul SK; Bethel MA; Neil HA; Matthews DR
    N Engl J Med; 2008 Oct; 359(15):1565-76. PubMed ID: 18784091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Control of blood pressure in diabetic patients in primary care setting. DIAPA study].
    García Vallejo O; Vicente Lozano J; Vegazo O; Jiménez Jiménez FJ; Llisterri Caro JL; Redón J;
    Med Clin (Barc); 2003 Apr; 120(14):529-34. PubMed ID: 12724064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register.
    Afghahi H; Svensson MK; Pirouzifard M; Eliasson B; Svensson AM
    Diabetologia; 2015 Jun; 58(6):1203-11. PubMed ID: 25773403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register.
    Cederholm J; Gudbjörnsdottir S; Eliasson B; Zethelius B; Eeg-Olofsson K; Nilsson PM;
    J Hypertens; 2010 Oct; 28(10):2026-35. PubMed ID: 20634718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria.
    Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P
    Eur J Clin Pharmacol; 2005 Aug; 61(7):483-90. PubMed ID: 16021438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should we change the target blood pressure in diabetic patients?
    Shlomai G; Grossman E
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():1-7. PubMed ID: 23280860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.
    Jansson SP; Svärdsudd K; Andersson DK
    Diabet Med; 2014 Sep; 31(9):1055-63. PubMed ID: 24894815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Blood Pressure and Other Clinical Variables on Long-Term Mortality in a Cohort of Elderly Subjects with Type 2 Diabetes.
    Tessier DM; Meneilly GS; Moleski L; Trottier L; Lanthier L
    Can J Diabetes; 2016 Feb; 40(1):12-6. PubMed ID: 26827682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden.
    Nilsson PM; Gudbjörnsdottir S; Eliasson B; Cederholm J;
    J Hum Hypertens; 2003 Jan; 17(1):37-44. PubMed ID: 12571615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
    Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H
    J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment and management of hypertension in patients with type 2 diabetes.
    Thomas MC; Atkins R
    Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteinuria modifies the effect of systolic blood pressure on total and cardiovascular disease mortality in patients with type 2 diabetes.
    Vepsäläinen T; Laakso M; Kantola I; Lehto S; Juutilainen A; Rönnemaa T
    J Intern Med; 2012 Dec; 272(6):611-9. PubMed ID: 22891848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood Pressure Management in Patients with Type 2 Diabetes.
    Eguchi K
    Intern Med; 2015; 54(18):2285-9. PubMed ID: 26370850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of microalbuminuria in 2 blood pressure categories of prehypertensive subjects.
    Kim BJ; Lee HJ; Sung KC; Kim BS; Kang JH; Lee MH; Park JR
    Circ J; 2007 Aug; 71(8):1283-7. PubMed ID: 17652896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension.
    Mucalo I; Jovanovski E; Rahelić D; Božikov V; Romić Z; Vuksan V
    J Ethnopharmacol; 2013 Oct; 150(1):148-53. PubMed ID: 23973636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world evidence of suboptimal blood pressure control in patients with type 2 diabetes.
    Walraven I; Mast MR; Hoekstra T; Jansen AP; Rauh SP; Rutters FR; van der Heijden AA; Elders PJ; Moll AC; Polak BC; Dekker JM; Nijpels G
    J Hypertens; 2015 Oct; 33(10):2091-8. PubMed ID: 26237560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR).
    Zethelius B; Eliasson B; Eeg-Olofsson K; Svensson AM; Gudbjörnsdottir S; Cederholm J;
    Diabetes Res Clin Pract; 2011 Aug; 93(2):276-284. PubMed ID: 21719139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population.
    Afghahi H; Miftaraj M; Svensson AM; Hadimeri H; Gudbjörnsdottir S; Eliasson B; Svensson MK;
    J Diabetes Complications; 2013; 27(3):229-34. PubMed ID: 23246248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.